seqWell was created to revolutionize NGS library prep to unlock the full potential of today's DNA sequencing instruments. Building on core strengths of molecular reagent design and workflow engineering, seqWell's product portfolio allows improvements in the scale and quality of DNA sequencing results. Our plexWell™ platform is a transformative library prep technology that allows for simple, scalable multiplexing of 100s to 1000s of samples without time- and cost-consuming normalization. plexWell has wide-ranging impact on applications from synthetic biology, targeted sequencing and single-cell analysis to low and high depth sequencing of human, plant, animal and microbial genomes.
In addition to plexWell, seqWell is also developing library prep methods for reagent-based approaches for long-molecule phasing and read linking.
Joseph Mellor, PhDFounder and Chief Executive Officer
Jack T. Leonard, PhDChief Technology Officer
Tom GrantChief Financial Officer
Chris BoggessVP, Commercialization
Ariele Hanek, PhDDirector, Research and Development
Fritz Roth, PhDProfessor, University of Toronto
Corey Nislow, PhDProfessor, University of British Columbia
Marc Vidal, PhDProfessor, Harvard Medical School and Dana-Farber Cancer Institute